HMGB1 and neoplasm: Recent reports have suggested that SDT can expose calreticulin (CRT) and release high mobility group box 1 (HMGB-1) in dying tumor cells to induce immunogenic cell death (ICD), which promotes the maturation of dendritic cells (DCs) and provokes an antitumor immune response 4, 5.